· National Academies of Sciences, Engineering, and Medicine, 2017
· 전방욱, 《DNA 혁명 크리스퍼 유전자가위》, 이상북스, 2017, p.24~25
· 양병찬. 유전자가위 논란의 배경. 주간조선(2355호) 2015.5.4.
· 박대웅, 류화신. (2016). 유전자편집 기술의 발전에 대응한 인간배아 유전자치료의 규제방향.
· 생명윤리, 17(1), 35-52.
· Charlesworth, C. T., Deshpande, P. S., Dever, D. P., Dejene, B., Gomez-Ospina, N.,
· Mantri, S., ... & Porteus, M. H. (2018). Identification of Pre-Existing Aadptive Immunity
· to Cas9 Proteins in Humans. bioRxiv, 243345
· 조은희. (2017). 배아 유전자 치료. 생명윤리, 18(2), 21-37.
· Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., ... & Sun, Y. (2015).
· CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & cell,
· 6(5), 363-372.
· Kang, X., He, W., Huang, Y., Yu, Q., Chen, Y., Gao, X., ... & Fan, Y. (2016).
· Introducing precise genetic modifications into human 3PN embryos by
· CRISPR/Cas-mediated genome editing. Journal of assisted reproduction and genetics,
· 33(5), 581-588.
· Tang, L., Zeng, Y., Du, H., Gong, M., Peng, J., Zhang, B., ... & Liu, J. (2017).
· CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein. Molecular
· Genetics and Genomics, 292(3), 525-533.
· Ma et al.," Correction of a pathogenic gene mutation in human embryos"(2017), Nature
· 548, 413–419.
· 기초과학연구원, “IBS 유전자가위 제공, 미 인간배아 유전자 변이 교정”, IBS 뉴스센터,
· 2017년 8월 3일자, <https://www.ibs.re.kr/cop/bbs/BBSMSTR_000000000735/
· selectBoardArticle.do?nttId=14783> (2019.10.18. 방문)
· Ewen Callaway, UK scientists gain licence to edit genes in human embryos, Nature
· News, February 1, 2016,
· http://www.nature.com/news/uk-scientists-gain-licence-to-edit-genes-in-human- embryos-1.19270 (2019.10.07.방문)